Oligometastases and oligo-recurrence: the new era of cancer therapy.

Oligometastases and oligo-recurrence: the new era of cancer therapy.
复制标题

DOI:
10.1093/jjco/hyp167
复制
发表时间:
2010-02
影响因子:
2.4
通讯作者:
Hayakawa K
Hayakawa K
中科院分区:
医学4区
文献类型:
--
作者:
Niibe Y;Hayakawa K

文献摘要

参考文献

被引文献

相似文献

癌症的复发或转移被认为发生在患者生命的最后阶段。然而,寡转移和寡复发的新概念已经提出,并在癌症转移或癌症复发的概念的范式转变。寡转移是患者仅在有限数量的区域中显示远处复发的状态。局部治疗,如手术,放射治疗和射频消融术的复发部位,因此可以提高患者的生存。另一方面,寡复发是类似于寡转移酶的概念。然而,寡复发的条件具有控制的癌症的原发部位,这意味着可以使用局部治疗来治疗所有大体复发或转移部位。
Recurrence or metastasis of cancer has been considered to occur in the last stage of the patient's life. However, the new notions of oligometastases and oligo-recurrence have been proposed and the paradigm shift in the conceptualization of cancer metastasis or cancer recurrence. Oligometastases is the state in which the patient shows distant relapse in only a limited number of regions. Local therapy such as surgery, radiotherapy and radiofrequency ablation for the relapsed sites could thus improve patient's survival. On the other hand, oligo-recurrence is a notion similar to oligometastases. However, the conditions of oligo-recurrence has a primary site of the cancer controlled, meaning that all gross recurrent or metastatic sites could be treated using local therapy.
DOI: 10.1016/s0360-3016(96)00619-0
发表时间: 1997-03-01
影响因子: 7
作者:
Gaspar, L;Scott, C;Byhardt, R
通讯作者: Byhardt, R
DOI: 10.3109/02841869509127197
发表时间: 1995-01-01
期刊: ACTA ONCOLOGICA
影响因子: 3.1
作者:
BLOMGREN, H;LAX, I;SVANSTROM, R
通讯作者: SVANSTROM, R
DOI: 10.1097/jto.0b013e318074de34
发表时间: 2007-07-01
影响因子: 20.4
作者:
Onishi, Hiroshi;Shirato, Hiroki;Araki, Tsutomu
通讯作者: Araki, Tsutomu
DOI: 10.1016/s0360-3016(01)02731-6
发表时间: 2002-03-15
影响因子: 7
作者:
Nagata, Y;Negoro, Y;Hiraoka, M
通讯作者: Hiraoka, M
DOI: 10.1016/j.ygyno.2006.03.034
发表时间: 2006-11-01
影响因子: 4.7
作者:
Niibe, Yuzuru;Kazumoto, Tomoko;Hayakawa, Kazushige
通讯作者: Hayakawa, Kazushige